Kirby has served in a wide array of senior and executive healthcare leadership positions within managed care, specialty pharmacy, healthcare consulting, healthcare technology, provider development, group purchasing, specialty distribution, and pharmaceutical manufacturers.

Before OutcomeRx, Kirby’s key roles and responsibilities included developing clinical oncology and specialty drug management solutions, business development, strategic planning, sales, and marketing representing organizations that included D2 Solutions, Onco360, CVS Health, CuraScript/ExpressScript, US Oncology, Oncology Therapeutics Network, Sicor, Fujisawa, and Eli Lilly & Company.

As Chief Clinical Officer for OutcomeRx, Kirby is responsible for creating and implementing practical cell and gene therapy clinical solutions that are patient-centered and align key stakeholders with costeffective options that complement OutcomeRx’s reinsurance and therapy warranty solutions.

Kirby is a licensed pharmacist with a B.S. in Pharmacy from the Arnold & Marie Schwartz College of Pharmacy and is an active member of the National Association of Specialty Pharmacy, the Academy of Managed Care Pharmacy, and the American Society of Gene & Cell Therapy.